Risk factors, clinical features and outcomes of visceral leishmaniasis in solid-organ transplant recipients: A retrospective multicenter case-control study

Clinical Microbiology and Infection

Volumn 21, Issue 1, 2015, Pages 89-95

  Clemente, W ^a   Vidal, E ^b,f   Girao E ^l   Ramos, A S D ^b,c   Govedic, F ^b,d   Merino, E ^m   Munoz P ^b,e   Sabe N ^b,g   Cervera, C ^b,h   Cota, G F ^a   Cordero, E ^b,i   Mena, A ^b,j   Montejo, M ^b,k   Lopez Medrano F ^b,d   Aguado, J M ^b,d   Fernandes, P ^l   Valerio, M ^b,e   Carratala J ^b,g   Moreno, A ^b,h   Oliveira, J ^a   Mourao P H O ^a   Torre Cisneros, J ^f   more..

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^f Maimonides Institute for Research in Biomedicine of Cordoba   (Spain)

^g BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^h UNIVERSITY OF BARCELONA   (Spain)

ⁱ HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^j HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^k HOSPITAL DE CRUCES   (Spain)

^l FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^m University General Hospital   (Spain)

more..

Author keywords

Parasitic infection; Posttransplant infection; Solid organ transplant; Tropical diseases; Visceral leishmaniasis

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; MEGLUMINE; MILTEFOSINE; PREDNISONE; ANTIINFLAMMATORY AGENT; ANTIPROTOZOAL AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BONE MARROW BIOPSY; BRAZIL; CASE CONTROL STUDY; CLINICAL FEATURE; CONCURRENT INFECTION; CONTROLLED STUDY; DELAYED DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEART TRANSPLANTATION; HEPATOSPLENOMEGALY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY (TOPIC); PANCYTOPENIA; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RECURRENT INFECTION; RELAPSE; RETROSPECTIVE STUDY; RISK FACTOR; SEPTIC SHOCK; SEROLOGY; TREATMENT DURATION; TREATMENT OUTCOME; VISCERAL LEISHMANIASIS; ADVERSE EFFECTS; CLINICAL TRIAL; LEISHMANIASIS, VISCERAL; MIDDLE AGED; MULTICENTER STUDY; ORGAN TRANSPLANTATION; SPAIN; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; ANTIPROTOZOAL AGENTS; CASE-CONTROL STUDIES; FEMALE; HUMANS; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; PREDNISONE; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN; YOUNG ADULT;

EID: 84926333684     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2014.09.002     Document Type: Article

References (30)

1. Antinori S., Cascio A., Parravicini C., Bianchi R., Corbellino M. Leishmaniasis among organ transplant recipients. Lancet Infect Dis 2008, 8:191-199.
2. Antinori S., Schifanella L., Corbellino M. Leishmaniasis: new insights from an old and neglected disease. Eur J Clin Microbiol Infect Dis 2012, 31:109-118.
3. Kotton C.N., Lattes R. Parasitic infections in solid organ transplant recipients. Am J Transplant 2009, 9(suppl. 4):S234-S251. AST Infectious Diseases Community of Practice.
4. van Griensven J., Carrillo E., López-Vélez R., Lynen L., Moreno J. Leishmaniasis in immunosuppresed individuals. Clin Microbiol Infect 2014, 20:286-299.
5. Postorino M.C., Bellantoni M., Catalano C., Caridi G., De Rosa M., Seck S., et al. Visceral leishmaniasis reactivation in transplant patients: a minireview with report of a new case. JNephrol 2011, 24:530-534.
6. Aardema H., Sijpkens Y.W., Visser L.G. Pancytopenia in a simultaneous pancreas and kidney transplant recipient: an unexpected cause-a case of visceral leishmaniasis in a transplant recipient. Clin Nephrol 2009, 71:460-462.
7. Basset D., Faraut F., Marty P., Dereure J., Rosenthal E., Mary C., et al. Visceral leishmaniasis in organ transplant recipients: 11 new cases and a review of the literature. Microbes Infect 2005, 7:1370-1375.
8. Campos-Varela I., Len O., Castells L., Tallada N., Ribera E., Dopazo C., et al. Visceral leishmaniasis among liver transplant recipients: an overview. Liver Transpl 2008, 14:1816-1819.
9. Clemente W.T., Faria L.C., Romanelli R.M., Lima S.S., Cortes J.R., Oliveira A.P., et al. Visceral leishmaniasis in liver transplant recipients from an endemic area. Transplantation 2011, 91:806-808.
10. Hernandez-Perez J., Yebra-Bango M., Jimenez-Martinez E., Sanz-Moreno C., Cuervas-Mons V., Alonso Pulpón L., et al. Visceral leishmaniasis (kala-azar) in solid organ transplantation: report of five cases and review. Clin Infect Dis 1999, 29:918-921.
11. Secretária de Vigilância em Saúde do Ministério de Saúde do Brasil. Leishmaniose visceral. Available at: . [accessed 03.03.13]. http://www.saude.gov.br/sinanweb.
12. Alves da Silva A., Pacheco-Silva A., de Castro Cintra Sesso R., Esmeraldo R.M., Costa de Oliveira C.M., Fernandes P.F., et al. The risk factors for and effects of visceral leishmaniasis in graft and renal transplant recipients. Transplantation 2013, 95:721-727.
13. World Health Organization (WHO) Control of the leishmaniases: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 22-26 March 2010 2010, World Health Organization, Geneva.
14. Oliveira C.M., Oliveira M.L., Andrade S.C., Girão E.S., Ponte C.N., Mota M.U., et al. Visceral leishmaniasis in renal transplant recipients: clinical aspects, diagnostic problems, and response to treatment. Transplant Proc 2008, 40:755-760.
15. Maggi P., Gaudiano V., Valente M., Latorraca A., Cavaliere R.L., Marroni M., et al. Leishmaniasis in patients with chronic renal failure: a diagnostic and therapeutic challenge for the clinician. JNephrol 2004, 17:296-301.
16. Souza R.M., de Oliveira I.B., Paiva V.C., Lima K.C., dos Santos R.P., deAlmeida J.B., et al. Presence of antibodies against Leishmania chagasi in haemodialysed patients. Trans R Soc Trop Med Hyg 2009, 103:749-751.
17. Bogdan C. Leishmaniasis in rheumatology, haematology and oncology: epidemiological, immunological and clinical aspects and caveats. Ann Rheum Dis 2012, 71(suppl. 2):i60-i66.
18. Veroux M., Corona D., Giuffrida G., Cacopardo B., Sinagra N., Tallarita T., et al. Visceral leishmaniasis in the early post-transplant period after kidney transplantation: clinical features and therapeutic management. Transpl Infect Dis 2010, 12:387-391.
19. Clemente W.T., Rabello A., Faria L.C., Peruhype-Magalhães V., Gomes L.I., daSilva T.A., et al. High prevalence of asymptomatic Leishmania spp. infection among liver transplant recipients and donors from an endemic area of Brazil. Am J Transplant 2014, 14:96-101.
20. Schwartz B.S., Mawhorter S.D. AST Infectious Diseases Community of Practice. Parasitic infections in solid organ transplantation. Am J Transplant 2013, 13:280-303.
21. Araujo S.A., Nascentes Queiroz T.C. Demas Alvares Cabral MM. Colonic leishmaniasis followed by liver transplantation. Am J Trop Med Hyg 2010, 83:209.
22. Jha P.K., Vankalakunti M., Siddini V., Babu K., Ballal S.H. Postrenal transplant laryngeal and visceral leishmaniasis-a case report and review of the literature. Indian J Nephrol 2012, 22:301-303.
23. Vargas A.A., Belchí S.E., Martinez C.A., Baños M.R., Pons M.J., Parrilla P.P. [Diarrhea due to visceral leishmaniasis in a liver transplant recipient]. Gastroenterol Hepatol 2013, 36:271-273.
24. Zümrütdal A., Erken E., Turunç T., Çolakoğlu Ş., Demiroğlu Y.Z., Özelsancak R., et al. Delayed and overlooked diagnosis of an unusual opportunistic infection in a renal transplant recipient: visceral leishmaniasis. Turkiye Parazitol Derg 2010, 34:183-185.
25. Martínez P., de la Vega E., Laguna F., Soriano V., Puente S., Moreno V., et al. Diagnosis of visceral leishmaniasis in HIV-infected individuals using peripheral blood smears. AIDS 1993, 7:227-230.
26. Omar M., Almagro M., Navarro J.M., Aliaga L. [Detection of leishmanias in peripheral blood]. Sangre (Barc) 1994, 39:228-229.
27. Bern C., Adler-Moore J., Berenguer J., Boelaert M., den Boer M., Davidson R.N., et al. Liposomal amphotericin B for the treatment of visceral leishmaniasis. Clin Infect Dis 2006, 43:917-924.
28. Meyerhoff A. US Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis. Clin Infect Dis 1999, 28:42-48.
29. Soto J., Soto P. Miltefosine: oral treatment of leishmaniasis. Expert Rev Anti Infect Ther 2006, 4:177-185.
30. Orlando G., Del Sorbo F., Corbellino M., Schiavini M., Cargnel A. Secondary prophylaxis for Leishmania infection in an HIV-positive patient. AIDS 1998, 12:2086-2087.